• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum.

作者信息

Alia Erisa, Varma Aakaash, Brody Joshua, Keyzner Alla, Singh Rajendra, Levitt Jacob

机构信息

Department of Dermatology, University of Connecticut, Farmington, Connecticut.

College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.

出版信息

JAAD Case Rep. 2020 Apr 24;6(6):567-568. doi: 10.1016/j.jdcr.2020.04.016. eCollection 2020 Jun.

DOI:10.1016/j.jdcr.2020.04.016
PMID:32509950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7265067/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/7265067/3f8655064928/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/7265067/3f8655064928/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5feb/7265067/3f8655064928/gr1.jpg

相似文献

1
Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum.依那西普在酪氨酸激酶抑制剂诱发的结节性红斑治疗中的应用。
JAAD Case Rep. 2020 Apr 24;6(6):567-568. doi: 10.1016/j.jdcr.2020.04.016. eCollection 2020 Jun.
2
Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia.一名慢性髓性白血病髓系原始细胞期患者在接受达沙替尼加化疗治疗后出现结节性红斑。
Clin Case Rep. 2023 Nov 22;11(11):e8223. doi: 10.1002/ccr3.8223. eCollection 2023 Nov.
3
Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.用肿瘤坏死因子抑制剂依那西普治疗重度难治性麻风结节性红斑。
Int J Mycobacteriol. 2016 Jun;5(2):223-5. doi: 10.1016/j.ijmyco.2016.02.002. Epub 2016 Feb 24.
4
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.酪氨酸激酶抑制剂时代慢性髓性白血病急变期患者的预后因素及生存结果：477例患者的队列研究
Cancer. 2017 Nov 15;123(22):4391-4402. doi: 10.1002/cncr.30864. Epub 2017 Jul 25.
5
Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.结节性红斑中肿瘤坏死因子-α启动子多态性
Acta Derm Venereol. 2001 Jan-Feb;81(1):18-21. doi: 10.1080/00015550116912.
6
The role of Fas-associated phosphatase 1 in leukemia stem cell persistence during tyrosine kinase inhibitor treatment of chronic myeloid leukemia.Fas相关磷酸酶1在慢性髓性白血病酪氨酸激酶抑制剂治疗期间白血病干细胞持续存在中的作用
Leukemia. 2016 Jul;30(7):1502-9. doi: 10.1038/leu.2016.66. Epub 2016 Mar 17.
7
Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.LYN 和 PTEN 基因在慢性髓性白血病中的表达及其在治疗策略中的重要性。
Blood Cells Mol Dis. 2014 Feb-Mar;52(2-3):121-5. doi: 10.1016/j.bcmd.2013.09.002. Epub 2013 Oct 3.
8
Use of tyrosine kinase inhibitors for chronic myeloid leukemia: management of patients and practical applications for pharmacy practitioners.酪氨酸激酶抑制剂在慢性髓性白血病中的应用：患者管理及药剂师的实际应用。
Ann Pharmacother. 2011 Jun;45(6):787-97. doi: 10.1345/aph.1P784. Epub 2011 Jun 13.
9
Erythema nodosum-like panniculitis associated with immune checkpoint inhibitor therapy: Two cases reporting a rare cutaneous adverse event.与免疫检查点抑制剂治疗相关的结节性红斑样脂膜炎：两例罕见皮肤不良事件报告
JAAD Case Rep. 2021 May 27;13:118-120. doi: 10.1016/j.jdcr.2021.05.002. eCollection 2021 Jul.
10
A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation.1例伴有ASXL1突变的酪氨酸激酶抑制剂耐药慢性期慢性髓性白血病病例
Case Rep Oncol. 2020 Apr 22;13(1):449-455. doi: 10.1159/000506452. eCollection 2020 Jan-Apr.

引用本文的文献

1
Erythema nodosum following treatment with dasatinib plus chemotherapy in a patient with myeloid blast phase of chronic myeloid leukemia.一名慢性髓性白血病髓系原始细胞期患者在接受达沙替尼加化疗治疗后出现结节性红斑。
Clin Case Rep. 2023 Nov 22;11(11):e8223. doi: 10.1002/ccr3.8223. eCollection 2023 Nov.
2
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm.结节性红斑：实用方法与诊断算法。
Am J Clin Dermatol. 2021 May;22(3):367-378. doi: 10.1007/s40257-021-00592-w. Epub 2021 Mar 8.

本文引用的文献

1
Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies.波纳替尼：一种新型的抗人类恶性肿瘤的多酪氨酸激酶抑制剂。
Onco Targets Ther. 2019 Jan 18;12:635-645. doi: 10.2147/OTT.S189391. eCollection 2019.
2
Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.TNFα、MAdCAM1 和 STAT3 在炎症性肠病肠道和皮肤表现中的表达模式。
J Crohns Colitis. 2018 Feb 28;12(3):347-354. doi: 10.1093/ecco-jcc/jjx158.
3
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum.
一系列结节性红斑患者的临床、组织病理学及免疫学评估
Int J Dermatol. 2016 May;55(5):e289-94. doi: 10.1111/ijd.13212. Epub 2016 Feb 24.
4
Ponatinib-induced neutrophilic panniculitis.波纳替尼诱发的嗜中性脂膜炎。
J Cutan Pathol. 2014 Jul;41(7):597-601. doi: 10.1111/cup.12326. Epub 2014 Apr 8.
5
TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature.肿瘤坏死因子-α抑制剂依那西普与血液系统恶性肿瘤：一例报告及文献复习
Am J Hematol. 2007 Nov;82(11):1022-4. doi: 10.1002/ajh.20926.
6
Etanercept treatment of erythema nodosum.依那西普治疗结节性红斑。
Skinmed. 2007 Jul-Aug;6(4):197-9. doi: 10.1111/j.1540-9740.2007.05882.x.
7
Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab.一名接受英夫利昔单抗治疗的类风湿关节炎患者并发慢性粒细胞白血病和肺结核。
Ann Rheum Dis. 2005 Mar;64(3):509-10. doi: 10.1136/ard.2004.021378.
8
Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.肿瘤坏死因子-α（TNF-α）及其可溶性I型受体（p55TNF-R）在某些药物性皮肤反应中的活性
Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):50-6.
9
Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.结节性红斑中肿瘤坏死因子-α启动子多态性
Acta Derm Venereol. 2001 Jan-Feb;81(1):18-21. doi: 10.1080/00015550116912.
10
Leucocyte activation in erythema nodosum.结节性红斑中的白细胞活化。
Clin Exp Dermatol. 1999 Sep;24(5):396-401. doi: 10.1046/j.1365-2230.1999.00511.x.